ArticleCureus2026
Thyroid Metastasis as the Initial Presentation of Occult Breast Carcinoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occult breast cancer (OBC) is a rare clinical entity characterized by metastatic disease in the absence of an identifiable primary breast lesion. Metastases to the thyroid gland are rare. Breast carcinoma infrequently metastasizes to the thyroid, and cases arising from OBC are exceptionally uncommon, posing a significant diagnostic challenge. We report the case of a 63-year-old woman with no prior history of malignancy who presented with diffuse abdominal pain, headache, and neck stiffness. A thyroid nodule was identified during diagnostic evaluation. Ultrasonography demonstrated a hypoechoic lesion with irregular margins, and core needle biopsy suggested malignancy. Immunohistochemical (IHC) analysis showed positivity for estrogen receptor (ER), progesterone receptor (PR), mammaglobin, and GATA3, with negativity for thyroglobulin (TG), PAX8, and thyroid transcription factor-1 (TTF-1), supporting a breast origin. Mammography and breast ultrasonography were negative. Breast magnetic resonance imaging (MRI) was not performed due to rapid clinical deterioration. During hospitalization, she developed a generalized tonic-clonic seizure. Imaging revealed multiple brain metastases, indicating advanced disease. This case underscores the diagnostic complexity of thyroid lesions and highlights the necessity of considering metastatic disease, particularly in the context of OBC. Accurate diagnosis requires comprehensive histopathological assessment supported by immunohistochemical profiling to reliably distinguish metastatic involvement from primary thyroid malignancies. Prompt recognition is crucial to inform optimal therapeutic decision-making in these challenging clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.